Welcome to this week's primary care bulletin

Key points this week include:

• Online consultation data due to be published
• Post covid video for professionals
• Ealing extranet to close on Friday 15 December
• Women's health in North West London - what are your experiences?
• NW London Elective Orthopaedic Centre (EOC)
• Diabetes early onset type 2 diabetes (EOT2D) clinical templates are now live
• Training, webinars and more

Data about the online consultation is due to be published on 30 November on the NHSE website.

This information is published to understand more about the scale of the patient demand for general practice services that is submitted to practices using Online Consultation Systems, and to learn more about patient use of digital tools to engage with healthcare services.

Click here to find out more including background information. 

Following the closure of our other borough extranets in NW London, the Ealing extranet is set to close on Friday 15 December.

You can continue to find information and resources aimed at primary care and health professionals on our website.

We are looking for insight from women who live in NW London about women’s health and well-being services and experiences. We want to better understand the unique challenges and experiences that women face in their healthcare journeys. Share your thoughts and experiences through our survey. 

Responses are confidential and the information provided will be used for NHS research purposes only. Sharing experiences will help us to understand the challenges women face in their healthcare journeys and how we can improve the quality of services for them. 

Click here to complete the survey.

Please share the survey link with those it may be relevant to. 

The North West London Elective Orthopaedic Centre (EOC) will welcome its first patients on the 4 December. 

The EOC will open with an initial operating capacity of three theatres, increasing to five theatres in February 2024. The centre will initially admit patients from Chelsea and Westminster Foundation Trust, Imperial College Healthcare Trust, and London North West University Healthcare Trust. Patients from The Hillingdon Hospitals Trust will be admitted as the EOC moves to full five-theatre capacity in February 2024.

The centre is based at Central Middlesex Hospital and will focus on ‘high volume, low complexity’ bone and joint procedures. This means patients who are accepted for the EOC will have been pre-operatively assessed as anaesthetically less complex, that is: ASA grades 1 and 2.

Full EOC details, including information and advice for patients is published on the LNWH website.

NHS NW London SystmOne and EMIS templates for the Early Onset Type 2 Diabetes (EOT2D) service is now available.  

NWL EMIS Practices: The templates will automatically appear in NW London resource publisher. They can be accessed via NWL F12 template launcher.
 
NWL EMIS PCNs: The templates will need to be manually imported. If you do not have these please email the service desk (nhsnwl.servicedesk@nhs.net). 
 
NWL SystmOne Practices: The templates will automatically be uploaded into your system.  
 
EOT2D is a two-year initiative (for 2023/24 and 2024/25) which aims to enhance the diabetes care provisions for the 9,135 patients aged 18-39 residing in NW London who are diagnosed with Early Onset Type 2 Diabetes (EOT2D).

The 30-minute patient reviews will attract an achievement of £52 per patient.  

Click here to download the diabetes early onset type 2 service specification

Click here to download NW London level 2 service FAQ's 

Wednesday 6 December 2023, 12:30 - 1:45pm

The webinar focuses in more detail on the incorporation of PCN companies. This includes:

• Why form a PCN company?
• Key considerations
• The practical steps to incorporation

Following the recent Framework Wave 3 contract procurement for the NHS Type 2 Diabetes Path to Remission Programme, NHS England has announced that Counterweight is the successful provider who will be delivering T2DR in NW London ICB/ ICS.

You will be able to refer your patients starting 1st February 2024. 

This service will be run by Counterweight, a leader in type 2 diabetes remission and weight loss. They were the intervention provider for the DiRECT clinical trial which showed an 87% remission in participants who lost over 15kgs. 

This webinar is intended for health care professionals and will cover what the programme is, how service users can gain access, and what is required from primary care staff. 

Counterweight invites you to join the webinar There are three identical webinars available on MS Teams:

· Tuesday 12th December 2023, 1.00 – 2.00pm       
Click here to join the meeting 

· Wednesday 10th January 2024, 5.00 - 6.00pm       
Click here to join the meeting 

· Thursday 15th February 2024, 12noon – 1.00pm       
Click here to join the meeting 

Put the date in your calendar today. Should you have any questions or require further information, please do not hesitate to reach out to nhsnwl.diabetes@nhs.net.